New vaccine for the prevention of Chikungunya

Chikungunya is a viral disease transmitted to humans by infected mosquitoes and is characterised by abrupt onset of fever with debilitating joint pain.

Unique selling point/competitive advantage

Currently, there is no cure or approved vaccine for prevention of Chikungunya. This new vaccine could help in preventing Chikungunya infection. It may also provide protection against other similar viruses.

Investment or collaboration opportunities

Griffith University is seeking to partner with a company that can further develop and bring this vaccine to market.

Griffith University is offering an exclusive licence to the intellectual property, know-how and materials, and access to their team for further joint research and development (R&D) and consultancy.

Intellectual property rights

Griffith University has full rights to this technology.

Contact

Griffith Enterprise
Phone: +61 7 5678 7536
Email: griffithenterprise@griffith.edu.au

More information

• Learn about Professor Suresh Mahalingam, the principal research leader for this vaccine.
• Visit Griffith Enterprise for more information.

Also consider...

• Read about other investment-ready opportunities.
• Discover collaboration opportunities.